3BILLION INC.

Products

Category

Product

Brand

Description

Rare Disease Diagnostics: Technologies and Global Markets (PHM227B)

3B-Genome		NGS-based WGS test. Scope incudes WGS +mtDNA. 3billion Inc. experts interpret all variant types, including SNVs, Indels, and SV with CNVs.
3B-Exome		NGS-based WES test. Scope incudes WES +mtDNA. Covers SNVs and DelIns in the protein-coding region (exome) and can also detect CNVs spanning more than three consecutive exons.
3B-Variant		Sanger sequencing is used to confirm specific, targeted variants. If a variant is detected through 3B-Genome or 3B-Exome, the patient or the patient’s family can conduct a 3B-Varaint test to confirm the detected variants.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment